Literature DB >> 27654285

Influenza Virus Susceptibility of Wild-Derived CAST/EiJ Mice Results from Two Amino Acid Changes in the MX1 Restriction Factor.

Cindy Nürnberger1,2, Vanessa Zimmermann1, Melanie Gerhardt1, Peter Staeheli3.   

Abstract

The interferon-regulated Mx1 gene of the A2G mouse strain confers a high degree of resistance against influenza A and Thogoto viruses. Most other laboratory inbred mouse strains carry truncated nonfunctional Mx1 alleles and, consequently, exhibit high virus susceptibility. Interestingly, CAST/EiJ mice, derived from wild Mus musculus castaneus, possess a seemingly intact Mx1 gene but are highly susceptible to influenza A virus challenge. To determine whether the enhanced influenza virus susceptibility is due to intrinsically reduced antiviral activity of the CAST-derived Mx1 allele, we generated a congenic C57BL/6J mouse line that carries the Mx locus of CAST/EiJ mice. Adult animals of this line were almost as susceptible to influenza virus challenge as standard C57BL/6J mice lacking functional Mx1 alleles but exhibited far more pronounced resistance to Thogoto virus. Sequencing revealed that CAST-derived MX1 differs from A2G-derived MX1 by two amino acids (G83R and A222V) in the GTPase domain. Especially the A222V mutation reduced GTPase activity of purified MX1 and diminished the inhibitory effect of MX1 in influenza A virus polymerase activity assays. Further, MX1 protein was substantially less abundant in organs of interferon-treated mice carrying the CAST Mx1 allele than in those of mice carrying the A2G Mx1 allele. We found that the CAST-specific mutations reduced the metabolic stability of the MX1 protein although Mx1 mRNA levels were unchanged. Thus, the enhanced influenza virus susceptibility of CAST/EiJ mice can be explained by minor alterations in the MX1 restriction factor that negatively affect its enzymatic activity and reduce its half-life. IMPORTANCE: Although the crystal structure of the prototypic human MXA protein is known, the importance of specific protein domains for antiviral activity is still incompletely understood. Novel insights might come from studying naturally occurring MX protein variants with altered antiviral activity. Here we identified two seemingly minor amino acid changes in the GTPase domain that negatively affect the enzymatic activity and metabolic stability of murine MX1 and thus dramatically reduce the influenza virus resistance of the respective mouse inbred strain. These observations highlight our current inability to predict the biological consequences of previously uncharacterized MX mutations in mice. Since this is probably also true for naturally occurring mutations in Mx genes of humans, careful experimental analysis of any natural MXA variants for altered activity is necessary in order to assess possible consequences of such mutations on innate antiviral immunity.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27654285      PMCID: PMC5110186          DOI: 10.1128/JVI.01213-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  THE RESISTANCE OF A2G MICE TO MYXOVIRUSES.

Authors:  J LINDENMANN; C A LANE; D HOBSON
Journal:  J Immunol       Date:  1963-06       Impact factor: 5.422

2.  Thogoto virus lacking interferon-antagonistic protein ML is strongly attenuated in newborn Mx1-positive but not Mx1-negative mice.

Authors:  Andreas Pichlmair; Johanna Buse; Stephanie Jennings; Otto Haller; Georg Kochs; Peter Staeheli
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  A high-resolution multistrain haplotype analysis of laboratory mouse genome reveals three distinctive genetic variation patterns.

Authors:  Jinghui Zhang; Kent W Hunter; Michael Gandolph; William L Rowe; Richard P Finney; Jenny M Kelley; Michael Edmonson; Kenneth H Buetow
Journal:  Genome Res       Date:  2005-02       Impact factor: 9.043

4.  Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A Viruses.

Authors:  Judith Verhelst; Jan Spitaels; Cindy Nürnberger; Dorien De Vlieger; Tine Ysenbaert; Peter Staeheli; Walter Fiers; Xavier Saelens
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

5.  Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly.

Authors:  Judith Verhelst; Eef Parthoens; Bert Schepens; Walter Fiers; Xavier Saelens
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

Review 6.  Mx GTPases: dynamin-like antiviral machines of innate immunity.

Authors:  Otto Haller; Peter Staeheli; Martin Schwemmle; Georg Kochs
Journal:  Trends Microbiol       Date:  2015-01-06       Impact factor: 17.079

7.  Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling.

Authors:  Dirk Holzinger; Carl Jorns; Silke Stertz; Stéphanie Boisson-Dupuis; Robert Thimme; Manfred Weidmann; Jean-Laurent Casanova; Otto Haller; Georg Kochs
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

8.  Mx1 gene protects mice against the highly lethal human H5N1 influenza virus.

Authors:  Rachelle Salomon; Peter Staeheli; Georg Kochs; Hui-Ling Yen; John Franks; Jerold E Rehg; Robert G Webster; Erich Hoffmann
Journal:  Cell Cycle       Date:  2007-07-22       Impact factor: 4.534

9.  Protection from Severe Influenza Virus Infections in Mice Carrying the Mx1 Influenza Virus Resistance Gene Strongly Depends on Genetic Background.

Authors:  Dai-Lun Shin; Bastian Hatesuer; Silke Bergmann; Tatiana Nedelko; Klaus Schughart
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

10.  Modeling host genetic regulation of influenza pathogenesis in the collaborative cross.

Authors:  Martin T Ferris; David L Aylor; Daniel Bottomly; Alan C Whitmore; Lauri D Aicher; Timothy A Bell; Birgit Bradel-Tretheway; Janine T Bryan; Ryan J Buus; Lisa E Gralinski; Bart L Haagmans; Leonard McMillan; Darla R Miller; Elizabeth Rosenzweig; William Valdar; Jeremy Wang; Gary A Churchill; David W Threadgill; Shannon K McWeeney; Michael G Katze; Fernando Pardo-Manuel de Villena; Ralph S Baric; Mark T Heise
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

View more
  6 in total

1.  Porcine Mx1 Protein Inhibits Classical Swine Fever Virus Replication by Targeting Nonstructural Protein NS5B.

Authors:  Jing Zhou; Jing Chen; Xiao-Min Zhang; Zhi-Can Gao; Chun-Chun Liu; Yun-Na Zhang; Jin-Xiu Hou; Zhao-Yao Li; Lin Kan; Wen-Liang Li; Bin Zhou
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

2.  Bayesian Diallel Analysis Reveals Mx1-Dependent and Mx1-Independent Effects on Response to Influenza A Virus in Mice.

Authors:  Paul L Maurizio; Martin T Ferris; Gregory R Keele; Darla R Miller; Ginger D Shaw; Alan C Whitmore; Ande West; Clayton R Morrison; Kelsey E Noll; Kenneth S Plante; Adam S Cockrell; David W Threadgill; Fernando Pardo-Manuel de Villena; Ralph S Baric; Mark T Heise; William Valdar
Journal:  G3 (Bethesda)       Date:  2018-02-02       Impact factor: 3.154

Review 3.  Mx genes: host determinants controlling influenza virus infection and trans-species transmission.

Authors:  Otto Haller; Georg Kochs
Journal:  Hum Genet       Date:  2019-11-26       Impact factor: 4.132

4.  Elucidating the characteristics of Mx1 and resistance to influenza A virus subtype H1N1 in the newly developed KWM/Hym mice.

Authors:  Hajin Nam; Boyoung Kim; Avishekh Gautam; Yoo Yeon Kim; Eun Sun Park; Jong Sun Lee; Hyung-Joo Kwon; Je Kyung Seong; Jun Gyo Suh
Journal:  Lab Anim Res       Date:  2022-09-08

5.  Vaccinia virus and Cowpox virus are not susceptible to the interferon-induced antiviral protein MxA.

Authors:  María M Lorenzo; Juana M Sanchez-Puig; Rafael Blasco
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

6.  A MicroRNA Network Controls Legionella pneumophila Replication in Human Macrophages via LGALS8 and MX1.

Authors:  Annalisa Marsico; Wilhelm Bertrams; Bernd Schmeck; Christina E Herkt; Brian E Caffrey; Kristin Surmann; Sascha Blankenburg; Manuela Gesell Salazar; Anna L Jung; Stefanie M Herbel; Kerstin Hoffmann; Leon N Schulte; Wei Chen; Alexandra Sittka-Stark; Uwe Völker; Martin Vingron
Journal:  mBio       Date:  2020-03-24       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.